Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 15, 2022

SELL
$0.98 - $2.57 $35,764 - $93,789
-36,494 Reduced 27.47%
96,371 $104,000
Q1 2022

May 16, 2022

SELL
$2.5 - $5.37 $118,115 - $253,711
-47,246 Reduced 26.23%
132,865 $335,000
Q4 2021

Feb 14, 2022

SELL
$4.86 - $8.37 $56,862 - $97,928
-11,700 Reduced 6.1%
180,111 $962,000
Q3 2021

Nov 15, 2021

SELL
$7.93 - $10.6 $18,239 - $24,380
-2,300 Reduced 1.18%
191,811 $1.66 Million
Q2 2021

Aug 11, 2021

SELL
$10.2 - $15.21 $63,739 - $95,047
-6,249 Reduced 3.12%
194,111 $1.99 Million
Q1 2021

May 17, 2021

BUY
$12.8 - $17.02 $2.56 Million - $3.41 Million
200,360 New
200,360 $2.55 Million

Others Institutions Holding BPTS

# of Institutions
1
Shares Held
0
Call Options Held
0
Put Options Held
0

About Biophytis SA


  • Ticker BPTS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 16,382,400
  • Market Cap $115M
  • Description
  • Biophytis S.A., a clinical-stage biotechnology company, focuses on the development of therapeutics that slow the degenerative processes and improve functional outcomes for patients suffering from age-related diseases. Its therapeutics focuses on targeting and activating key biological resilience pathways that could protect against and counteract...
More about BPTS
Track This Portfolio

Track Cvi Holdings, LLC Portfolio

Follow Cvi Holdings, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cvi Holdings, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cvi Holdings, LLC with notifications on news.